Loading...

Shattuck Labs ($STTK)

Stock Image

STTK Overview

Shattuck Labs, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian cancer. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma.The company was founded in 2016 and is headquartered in Austin, Texas. (From: StockAnalysis.com)

MORE ABOUT Shattuck Labs

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.

CONVERSATIONS ABOUT Shattuck Labs